Antisense Oligonucleotide Therapy for Lafora Disease

被引：0
|
作者：
Ahonen, Saija [1 ]
Grossman, Tamar [2 ]
Turnbull, Julie [1 ]
Kordasiewicz, Holly [2 ]
Katz, Melanie [2 ]
McCaleb, Michael [2 ]
Wang, Peixiang [1 ]
Zhao, Xiaochu [1 ]
Minassian, Berge [3 ]
机构：
[1] Hosp Sick Children, Toronto, ON, Canada
[2] Ionis Pharmaceut, San Diego, CA USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S53.005
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model
    Donohue, Katherine J.
    Fitzsimmons, Bethany
    Bruntz, Ronald C.
    Markussen, Kia H.
    Young, Lyndsay E. A.
    Clarke, Harrison A.
    Coburn, Peyton T.
    Griffith, Laiken E.
    Sanders, William
    Klier, Jack
    Burke, Sara N.
    Maurer, Andrew P.
    Minassian, Berge A.
    Sun, Ramon C.
    Kordasiewisz, Holly B.
    Gentry, Matthew S.
    NEUROTHERAPEUTICS, 2023, 20 (06) : 1808 - 1819
  • [32] Antisense Oligonucleotide-Based Therapy of Viral Infections
    Tarn, Woan-Yuh
    Cheng, Yun
    Ko, Shih-Han
    Huang, Li-Min
    PHARMACEUTICS, 2021, 13 (12)
  • [33] Respirable antisense oligonucleotide (RASON) therapy for allergic asthma
    Metzger, WJ
    Nyce, JW
    BIODRUGS, 1999, 12 (04) : 237 - 243
  • [34] ONE ANTISENSE OLIGONUCLEOTIDE AS A POTENTIAL THERAPY FOR POLYGLUTAMINE DISORDERS
    van Roon-Mom, W. M. C.
    Evers, M. M.
    van Deutekom, J. C. T.
    Mulders, S. A. M.
    Aartsma-Rus, A. M.
    den Dunnen, J. T.
    van Ommen, G-J B.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A13 - A13
  • [35] Antisense oligonucleotide mediated therapy of spinal muscular atrophy
    Sivanesan, Senthilkumar
    Howell, Matthew D.
    DiDonato, Christine J.
    Singh, Ravindra N.
    TRANSLATIONAL NEUROSCIENCE, 2013, 4 (01) : 1 - 7
  • [36] Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
    Daniel R. Scoles
    Pratap Meera
    Matthew D. Schneider
    Sharan Paul
    Warunee Dansithong
    Karla P. Figueroa
    Gene Hung
    Frank Rigo
    C. Frank Bennett
    Thomas S. Otis
    Stefan M. Pulst
    Nature, 2017, 544 : 362 - 366
  • [37] Antisense oligonucleotide therapy for KCNT1 encephalopathy
    Burbano, Lisseth Estefania
    Li, Melody
    Jancovski, Nikola
    Jafar-Nejad, Paymaan
    Richards, Kay
    Sedo, Alicia
    Soriano, Armand
    Rollo, Ben
    Jia, Linghan
    V. Gazina, Elena
    Piltz, Sandra
    Adikusuma, Fatwa
    Thomas, Paul Q.
    Kopsidas, Helen
    Rigo, Frank
    Reid, Christopher A.
    Maljevic, Snezana
    Petrou, Steven
    JCI INSIGHT, 2022, 7 (23)
  • [38] Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
    Scoles, Daniel R.
    Meera, Pratap
    Schneider, Matthew D.
    Paul, Sharan
    Dansithong, Warunee
    Figueroa, Karla P.
    Hung, Gene
    Rigo, Frank
    Bennett, C. Frank
    Otis, Thomas S.
    Pulst, Stefan M.
    NATURE, 2017, 544 (7650) : 362 - +
  • [39] Respirable Antisense Oligonucleotide (RASON) Therapy for Allergic Asthma
    W. James Metzger
    Jonathan W. Nyce
    BioDrugs, 1999, 12 : 237 - 243
  • [40] TRIPLE BROMIDE THERAPY IN A CASE OF LAFORA DISEASE
    Kimler, Katelin
    Shah, Pooja
    Gertz, Shira
    Siegel, Mark
    Segal, Eric
    CRITICAL CARE MEDICINE, 2016, 44 (12)
12345